Contact us

Active Substances and Excipients Training



5 days


In-Person - Newcastle, United Kingdom


About This Course

This Active Substances (AS) and Excipients training course gives a unique insight into the regulatory expectations associated with producing both chemically synthesized and biological/biotech ASs. The course also provides insight and expertise on managing global AS supply chains, vendor quality assurance and “how to audit” AS facilities. We summarise the key steps in identifying and removing impurities, including some updated information on the impact of potential nitrosamine formation. During the course we will also visit Active Substance manufacturing facilities to see how the theoretical requirements are implemented in real life.

This course fulfils the requirements of the Qualified Person Study Guide and we don’t just train to pass a viva, we take the time to prepare you for your career ahead.

This course is approved by the Royal Society of Chemistry as suitable for its members’ continuing professional development.

Key Learning Objectives

As AS supply chains become ever more diverse and cost pressures more acute, the pharma manager needs a keen appreciation of risk factors, design, control and monitoring of AS sources. This course allows delegates to differentiate between natural variation and risk across a range of AS processes, indicating the most appropriate and proportionate actions to take to mitigate any areas of concern.

You will be provided with an overview of the EU and US regulatory framework surrounding active substance and excipient manufacturing process and be given practical guidance on the key responsibilities of the Qualified Person when approving a GMP declaration.

You will also learn:

  • How to meet EU and US Regulatory requirements and GMP guidance
  • The major differences between chemical synthesis and bioprocesses; and contrasting both against drug product formulation
  • How to manage change of AS source
  • How to audit and provide QA oversight of excipients and Active Substances

The course will also allow you to make informed decisions when faced with a range of GMP non-conformances during AS production.

Our detailed educational material grows into a lifelong reference library.

Course Content

For chemically synthesized and biological/biotech produced APIs, the course includes:

  • Common process steps and their effect on the quality of the final drug substance
  • EU and US regulatory requirements
  • Comparison and contrast of AS facilities
  • How GMP is implemented across the key production processes from AS starting materials through to packaging and distribution
  • Vendor assurance and management of supply chains including auditing of facilities

Course Outline

Active Pharmaceutical Ingredients

  • The regulations
      • EU and US regulations and guidelines
      • Active Substance master files and certificates of suitability
      • Key GMP guidance –EudraLex Volume IV Parts 2 and 4 and Annex 2
    • Manufacturing processes and quality
      • Key issues for:
        • Synthesis
        • Purification and impurity control
        • Packaging
    • Supply issues for the dosage form manufacturer
      • Supplier selection and audit
      • Supply chain integrity
      • Technical/quality agreements
      • Certificates of analysis

Bulk Biologicals and Biotech Products

  • What is a biological or biotech product?
  • EU and US regulatory aspects
  • Essential characteristics of biologicals
  • Premises and Facilities
  • Quality aspects
    • Control of starting materials
    • Control of cultivation, harvest and purification
    • Reducing risk of viral contamination
    • QC Strategy for Biopharmaceuticals


  • Regulatory environment
  • GMP guidances/codes

Who Should Attend

The Aspiring Qualified Person

  • Our training is generally considered as the best available and our QPs are held in high regard within the industry
  • In addition to being accepted in the UK, our training courses are well known and accepted by several EU countries, including Ireland, The Netherlands, Austria, Hungary and Malta
  • You are more likely to become a QP with us than with any other training provider!

The Pharmaceutical Technical Professional

  • Not all people attending these courses intend to become QPs. Many use the training to develop as technical managers within other areas of pharmaceutical manufacture and control
  • Many industry professionals from a range of disciplines attend the courses as part of their continuing professional development. Taken with some of our other QP modules, this course is designed to lead to postgraduate certificate, diploma and MSc qualifications

Course Tutors

Course tutors will be selected from the following:

David Waddington – David’s career in the pharmaceutical industry spans more than 30 years in various quality roles for three major international pharmaceutical organizations. Dave is eligible to act as a Qualified Person under the permanent provisions. He has broad experience in QA and manufacturing management gained through working with a wide range of dosage forms for global supply, including solids, liquids, sterile products, food supplements and natural products.

Neil Wayman – Neil is an experienced quality professional with over 30 years of experience in pharmaceutical quality. Neil has worked as a QP and RP and has experience of Stability testing and the manufacture of APIs , solid oral dose and sterile injectables (terminally sterilised and aseptic). Neil has extensive experience managing all aspects of manufacturing site and global quality management systems, including inspection/audit management, issue management and site remediation, as well as global supply chain assurance activities associated with external manufacture and distribution.

Robert Smith – Robert has more than 30 years’ experience in the pharmaceutical industry, in various production and quality roles for a number of major international organizations. He is eligible to act as a Qualified Person under the permanent provisions for both commercial and investigational medicinal products. He is a QP assessor and Vice Chair of the Royal Pharmaceutical Society Panel of Assessors. Robert has broad experience in QA and manufacturing management gained through working with a wide range of dosage forms for both commercial and clinical supply, including solids, liquids, sterile products, vaccines, biological, biotechnology, viral vectors, gene therapy and cellular therapy products.

Eurwyn Roberts – Eurwyn has over 30 years’ operational QA and management experience in vaccine and therapeutic biological product manufacture across process and analytical development, technology transfer and as a QP for clinical and commercial manufacture of API and sterile small volume liquid and lyophilised drug products.


Multi-delegate discounts available. Discounts also offered to NHS staff and charities.

Qualified Person Training With NSF

Watch the video
  • Site visits were excellent and really helped put things into ‘real’ application. Buzz groups were useful and relevant. Very informative, useful and enjoyable.
    Helen Neal
    Reckitt Benckiser Healthcare, UK
  • Very good course and experienced tutors.
    Ineta Sudmale
    JSC Olainfarm, Latvia

Additional Recommended Courses

CQI & IRCA-certified QMS Lead Auditor based on ISO 13485:2016 and MDSAP Requirements

This virtual instructor-led CQI/IRCA accredited course provides learners with the skills and knowledge that have taken many ​experienced ​auditors ​decades ​to ​develop. This course is fundamental to achieving CQI/IRCA Lead Auditor status. ​During ​the ​course, ​learners ​will ​plan, perform, ​and ​report ​audits ​based ​on ​case ​studies ​that ​simulate ​internal, ​supplier, ​and ​third-party ​audits ​utilizing ​MDSAP ​audit criteria. ​Learners ​will ​participate ​in ​simulated ​auditing ​exercises ​that ​include ​planning and performing audit activities, ​evaluating ​audit ​evidence, and documenting audit findings.

The course consists of five days of interactive instruction and auditing sessions followed by a comprehensive written examination on day six. Learners will have two hours to complete the exam, which is provided and proctored in a virtual format (additional time will be added for non-native English-speaking learners, and learners with disabilities).

Learners should enter the QMS Lead Auditor course with a basic understanding of ISO 13485:2016. Mandatory prerequisite reading and a prerequisite competency assessment will be provided upon enrollment. These prerequisites must be completed in advance of the course start date.

Ask about our discount pricing when bundling courses together. We can also bring this course to your individual organization through virtual instructor-led or face-to-face training.

This class is helpful for all personnel involved in preparing, conducting, managing, participating in, or otherwise facilitating internal, supplier, or regulatory audits and their outcomes, as well as executive personnel with responsibility for the design and implementation of any aspect of a quality management system.

By the end of this course you should be able to:

· Describe the purpose of:

  • Quality management systems
  • Quality management system standards
  • Management system audits
  • Third-party certification

· Explain the role of an auditor to plan, conduct, report and follow up a quality management system audit in accordance with ISO 19011:2018

· Plan, conduct, report and follow up an audit of a quality management system to establish conformity (or otherwise) with ISO 13485:2016 and MDSAP participating country-specific requirements.

Price: $2800.00

MDSAP Internal Auditor Training

This virtual instructor-led course was designed and developed by the Medical Device Single Audit Program (MDSAP) Lead Project Manager responsible for the team that designed, implemented, and maintained the MDSAP program.

This training focuses internal auditors on the applicable MDSAP country-specific requirements that are applicable to the auditee organization. This focus, when used in conjunction with an existing ISO 13485 internal audit program, will provide the comprehensive coverage necessary to assure all applicable MDSAP regulatory requirements are audited. In addition, resources and insight into how MDSAP Auditing Organizations establish competence of their auditors will be discussed.

An “MDSAP Lite” audit tool will be provided including country-specific requirements and hyperlinks to the specific regulatory requirements (audit criteria) relative to each country-specific requirement. Through expertly designed individual and group tasks and activities, learners will demonstrate how to identify applicable country-specific requirements, how to plan the time necessary to conduct the audit of applicable country-specific requirements, how to plan an MDSAP Lite audit, as well as how to identity, document, and grade country-specific nonconformities.

This training is essential to anyone engaged in planning or conducting internal audits of an organization participating in MDSAP.

Ask about our discount pricing when bundling courses together. We can also bring this course to your individual organization through virtual instructor-led or face-to-face training.

By the end of this training you should be able to:

  • Describe an MDSAP Audit and identify criteria used during an MDSAP Audit
  • Recognize International Medical Device Regulators Forum (IMDRF) governing procedures relative to MDSAP Auditing Organizations
  • Recognize the competency and training requirements for AO auditors
  • Recognize the structure and utility of the “MDSAP Lite” internal audit approach and “Toolkit”
  • Calculate audit time and plan an MDSAP Lite internal audit
  • Identify nonconformities, write nonconformity (NC) statements, and support the nonconformity statements with audit evidence
  • Identify post-audit MDSAP activities including NC grading
  • Recognize the outcomes and goals of an MDSAP audit

Price: $1200.00

EU IVDR Internal Auditor

This virtual instructor-led two-day course provides guidance on how to prepare for, plan, and conduct an internal or supplier audit based on the EU IVDR. This course also focuses on ISO 13485:2016 relative to its correspondence with the EU IVDR.

This course provides practical instruction for auditors and managers performing, facilitating, or managing internal and supplier audits against criteria contained within the European Union In Vitro Diagnostic Regulation (EU IVDR).  The instructor will review the regulation in depth from the auditor’s perspective and provide practical instruction for preparing for, planning and conducting EU IVDR audits according to NSF’s formal, documented EU IVDR Audit Model.

This course includes a two-hour eLearning prerequisite module, EU IVDR – A Comprehensive Overview, to be completed prior to the start of the live instruction. The self-paced eLearning covers every aspect of the regulation and identifies key pre- and post-market requirements associated with EU IVDR – standard regulatory requirements that must be met by all In Vitro Diagnostic manufacturers wishing to do business in the EU regardless of IVD classification.

Ask about our discount pricing when bundling courses together. We can also bring this course to your individual organization through virtual instructor-led or face-to-face training.

By the end of this training you should be able to:

  • Identify Key Articles and Annexes of the EU IVDR
  • Recognize Intent of Requirements as Described in Recitals
  • Identify Classification Implementing and Classification Rules
  • Identify General Safety and Performance Requirements (GSPRs)
  • Recognize Content of Technical Documentation
  • Identify Post-Market Surveillance Reporting and Vigilance Obligations
  • Recognize one EU IVDR Audit Model
  • Plan an EU IVDR Audit
  • Document Nonconformities against EU IVDR requirements

Who should attend:

This course is helpful for experienced internal auditors seeking to expand their auditing knowledge of the EU IVDR, for managers of audit programs, and for anyone who will be the subject of or participate in an EU IVDR audit. Delegates should have some internal audit experience and ideally have certified auditor/lead auditor qualifications in QMS audits.

Price: $1200.00